Replies to post #236724 on Biotech Values

[lgonber]

Yes, 2 recently approved products, management looks strong with proven M&A success. They have money. I also like and own OCUL in same space. GL

[DewDiligence]

KALA sells Kala Eysuvis and Inveltys to Alcon for $60M up-front plus milestone payments:

https://finance.yahoo.com/news/kala-announces-entry-definitive-agreement-040100150.html